FREMONT, Calif.--(BUSINESS WIRE)--Lecorpio, the leader in intellectual property (IP) management and analytics software solutions, announced today that global biopharmaceutical company PTC Therapeutics (PTC) has selected Lecorpio Intellectual Property Management. PTC discovers, develops, and markets small molecule drugs worldwide, targeting rare genetic disorders, and cancer. Lecorpio’s solution will enable the company to maximize the efficiency of its in-house IP processes so that all activities, including patent prosecution and annuity payments can be managed from a single, secure online environment.
Prior to purchasing the Lecorpio system, the IP management software PTC was using no longer met its needs. Paul Martin, patent attorney at PTC Therapeutics, sought a solution incorporating document management, text-mining, USPTO integration and clear, easy-to-understand reporting to show real-time status of the company’s patent portfolio: “We needed a system having greater functionality, capable of easily tracking and reporting patent and application status, providing access to archived documents, streamlining patent prosecution and providing greater transparency to stakeholders. After thoroughly reviewing 5 different systems, Lecorpio stood-out with the integration of these capabilities and the ability to customize the system to meet our needs. Moreover, Lecorpio showed us how we could significantly reduce our annuity spend by integrating their annuity service into the system.”
Lecorpio’s secure, cloud-based interface for docketing and annuities will streamline PTC’s workflow. It will save time by integrating emails and documents in one place, and will provide text-searching so users can quickly locate documents.
Lecorpio CEO Jay Madsen remarked, “PTC Therapeutics is a distinguished biopharmaceutical leader. We are thrilled to offer them our state-of-the-art, secure IP management system. Our objective is to help them not only simplify the management of their IP, but to also provide them with the information that they need to make informed, data-driven decisions to reduce risks and maximize value.”
About Lecorpio, LLC
Lecorpio, the leader in IP management and analytics software solutions, helps innovative companies quickly turn ideas into assets. The company’s enterprise-class suite of applications spans the entire IP supply chain, including invention disclosure management, patent and trademark management, e-billing, licensing management and general matters management. The Lecorpio solution includes powerful workflow capabilities that easily configure to a company’s business process and includes an IP dashboard with over 160 KPIs.
Primarily marketed to corporate law departments specializing in IP matters, Lecorpio’s adaptable IP management software-as-a-service creates one central repository for IP information. Lecorpio’s powerful solution simplifies data management processes for attorneys and paralegals through the entire IP lifecycle, from invention disclosure to patent management to billing, monetization and litigation. Also, Lecorpio helps clients to control costs by automating processes and increasing efficiency.
Lecorpio is used by 5 of the top 20 most active US patent filers, in addition to well-known innovators such as Adobe, T-Mobile, Analog Devices, Rockwell Automation, NEC, NetApp and Red Hat. Visit http://www.lecorpio.com for more information.
Contacts
Media:
Burke & Company
Christy Burke, 917-623-5096
cburke@burke-company.com